biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by roadking08on Jan 18, 2018 6:41pm

118 Views

Post# 27389383

RE:RE:RE:Up

Here is my unformed guess, bioasis will be at least 3 bucks in American dollars by the American thanksgiving. That’s folks is up for debate with anyone that could of guess last year that early this year we would be telling young adults to not eat tide pods we put to wash our clothes.
Ive already advised my son to buy BTI with his spare change and to not think the pink insulation in between my house walls is cotton candy.

Just when I thought I had seen it all.....

Bullboard Posts

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta